Harte Hanks (HHS) Liabilities and Shareholders Equity (2010 - 2026)

Harte Hanks (HHS) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $90.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 10.12% year-over-year to $90.4 million; the TTM figure through Mar 2026 stood at $370.0 million (down 11.96% YoY), while the FY2025 annual figure was $91.8 million, down 9.78% from the prior year.
• Liabilities and Shareholders Equity retreated to $90.4 million in Q1 2026 per HHS's latest filing, from $91.8 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $122.8 million in Q4 2023 and bottomed at $90.4 million in Q1 2026.
• Historically, Liabilities and Shareholders Equity has averaged $107.2 million across 5 years, with a median of $110.8 million in 2023.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity rose 11.24% — and 2024, when it decreased 17.09%.
• Harte Hanks' Liabilities and Shareholders Equity stood at $120.0 million in 2022, then climbed by 2.31% to $122.8 million in 2023, then fell by 17.09% to $101.8 million in 2024, then retreated by 9.78% to $91.8 million in 2025, then slipped by 1.55% to $90.4 million in 2026.
• Business Quant data shows HHS's Liabilities and Shareholders Equity at $90.4 million in Q1 2026, $91.8 million in Q4 2025, and $92.7 million in Q3 2025.